Pay in 4 interest-free payments of $7.19 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Endothelial dysfunction is a significant component of HFpEF pathophysiology, and glucagon-like peptide-1 receptor (GLP-1R) agonists have shown potential benefits in improving endothelial function
(Shelby Knowles/Bloomberg via Getty Images) The market for so-called GLP-1 drugs has become increasingly competitive and a shift to consumer-driven, cash-pay channels is making price points more sensitive
It's optional, but most patients say it's the moment when everything clicks and makes sense
The new small-molecule GLP-1 pills should cost less to make and distribute than todays injectables, which require refrigeration and a more complex manufacturing process
We bring decades of private-sector expertise and experience in the field of intellectual property as well as the pharmaceutical sector
US$ 25.01
US$ 29.76
US$ 29.64
US$ 24.16
US$ 21.16
US$ 20.88
